SUMMARY
Iron deficiency anaemia is known to be associated with increased infection risk, impaired immunity, impaired myocardial function, thermoregulation, mental function and physical performance. These problems occur in the presence of iron deficiency before anaemia develops 1 . Functional iron deficiency (FID) represents an inability to utilize iron in biological processes: this may be independent of total body iron stores.
Measures of FID include presence of zinc protoporphyrin 2,3 and percentage of hypochromic red blood cells 4, 5 . An erythrocyte is defined as hypochromic if its haemoglobin concentration is less than 28 g.dl -1 . FID is considered present when more than 10% of red blood cells exhibit hypochromasia as assessed by flow cytometry 4 . These changes are seen before changes in ferritin, transferrin and haemoglobin. FID has been described in chronic renal failure patients when the mobilization of iron in response to treatment with erythropoietin is inadequate to meet the demands of erythropoesis 4 . Patients with FID respond to intravenous iron by increased erythropoiesis. Elevated red cell hypochromasia predicts those patients who will respond to intravenous iron. FID has also been described in patients with chronic infection and in postoperative liver transplant patients 6, 7 . In these patient groups, it is associated with poor outcome.
The primary aim of this study was to describe the prevalence of FID in patients presenting to intensive care and the relationship to length of stay within ICU. Mortality and total hospital stay was also examined. As iron deficiency is implicated in both immune compromise and as a protective mechanism to reduce bacterial growth in the anaemia of chronic disease 8 , differences between the presence and development of infection were examined between the two groups.
MATERIALS AND METHODS
Hospital Ethics Committee approval was obtained. All patients or their representatives gave written informed consent prior to inclusion in the study. In this prospective observational study, consecutive adult (>18 years old) patients presenting to the general intensive care unit of a tertiary referral teaching hospital over a six-week period were investigated. Exclusion criteria were massive haemorrhage/exchange transfusion (>8 units) in the two weeks prior to admission, pregnancy/lactation, age >80 years, haematological malignancy or existing bone marrow depression. Data were not collected on patients discharged to the ward within four hours of intensive care admission. Fifty-one patients were recruited during the study period, of a total 150 admissions. The low recruitment rate was due to difficulty contacting relatives and gaining informed consent for study inclusion within twenty-four hours of admission, and patients with an expected length of stay less than 24 hours.
Blood samples were drawn from a radial artery line on patient admission and subsequent samples at 7 a.m. on days when study samples were required. All patients were monitored using a Mennen Horizon monitoring system (Mennen Medical, Tel Aviv, Israel). Patient data were collated from beside monitors, casenotes and patient intensive care charts. All patients were managed by physicians according to their normal practice. Study data were stored separately from patient casenotes and were neither disclosed to the clinician managing the case nor used for patient management decision-making.
Demographic data included age, gender, surgical/non-surgical admission, acute physiological and chronic health evaluation (APACHE II) score 9 , sequential organ failure assessment (SOFA) score 10 , and "elective" versus "emergency" admission. Elective admission was defined as a planned admission (following elective surgery or non-surgical procedure). Emergency admission was defined as unexpected or unplanned admission, or admission for resuscitation.
We measured haemoglobin concentration, serum ferritin and transferrin concentrations and the percentage of hypochromic erythrocytes on admission. Standard haematological variables and proportion of hypochromic red blood cells were measured by flow cytometry using a Bayer H3 Hematology Analyzer (Bayer, Tarrytown, NY, U.S.A.). C-reactive protein (CRP) was measured on day 3 as an indicator of inflammation. We additionally recorded episodes of infection as evidenced by positive, clinically significant cultures arising before or during intensive care treatment. The decision to perform an infection screen was based on the clinical condition of the patient, by the physician responsible for the patient's care. Haemoglobin, albumin, creatinine, bilirubin concentrations and white blood cell and platelet counts were recorded on admission and days 3, 7 and 14.
The prevalence of FID (hypochromasia exceeding 10%) on admission was calculated. We compared demographic data and outcome between patients with and without FID to assess the association between FID and outcome. The primary outcome variable was duration of ICU stay, and secondary variables included hospital stay and mortality. The time course and relationship between FID, clinical data and infection were examined. We compared sequential SOFA score (days 1, 3, 7, 14 after admission) and incidence and duration of the systemic inflammatory response syndrome (SIRS) 11 between groups 12 . Data were stored anonymously on a desktop PC. Statistical analysis was performed using SPSS for Windows 6.0. Results, expressed as median (interquartile range) or mean (95% confidence interval) as appropriate, were analysed by Fisher's exact test for categorical variables, Mann-Whitney U test for ordinal variables and Kaplan-Meier analysis with between-group differences compared by the log-rank test for survival and length-of-stay data. Sequential SOFA scores were compared by Friedman analysis of variance. The assumption of normality was tested by the Kolmogorov-Smirnov test. Statistical significance was assumed at P<0.05.
RESULTS
FID was present in 35% (22 to 48%, 95% CI) of patients at ICU admission, as defined by more than 10% of red blood cells exhibiting hypochromasia. There was no significant difference between FID and non-FID patients in the need for emergency admission, age, diagnosis or standard haematological parameters.
Patients with FID had a prolonged ICU stay compared to those patients without FID. Mean ICU stay (days) was 7.6 (4.4-10.8, 95%CI) v 3.3 (2.0 to 4.5, 95%CI), P<0.0007 ( Figure 1 ). In those patients who survived to be discharged from ICU, length of stay was similarly greater in patients with FID than in those with less than 10% red cell hypochromasia ( Figure 2 ). Severity of hypochromasia was correlated with duration of ICU stay (P=0.017) (Figure 3 ). There was no statistical difference in serum albumin, creatinine concentration or white cell count on admission and days 3, 7 and 14. Day 3 CRP was higher in the FID group mean 155 (101 to 209, 95% confidence interval) v 120 (91 to 149, 95% CI), although this was not statistically significant. The incidence of positive cultures between the two groups was similar, 9/18 patients with FID and 15/33 patients without FID. Time to development of positive cultures was similar between FID and non-FID patients, 6.7 (1.5 to 11.9) versus 4.9 (2.3 to 7.5) days. Two patients had positive cultures prior to admission (both non-FID). FID developed in five patients during their stay in intensive care. In these patients, there was no relationship between new FID and infection (4/27 without infection versus 1/24 with infection).
By logistic regression (using a backward WALD model), FID was associated only with abnormal white blood cell count (WBC <4 or >11x10 9 the model were demographic data as well as haematological and biochemical parameters. Duration of episodes of SIRS was greater in the FID group, 8.4 (5.4 to 11.4, 95%CI) compared with the non-FID group, 4.6 (2.6 to 6.5, 95% CI), P<0.02. SOFA scores improved in both patient groups over time (P<0.001) and were lower in the non-FID group, though this was not statistically significant (Table 2) .
DISCUSSION
In this study, FID (as assessed by red cell hypochromasia) is seen in critically ill patients presenting to intensive care. It is associated with a prolonged stay in the intensive care unit and a prolonged period of SIRS, but not with patient demographics, APACHE II score or differences in haematological or biochemical variables. Moreover, severity of FID correlated with duration of ICU stay. These differences remained after correction for survival, i.e., when "time to reach treatment endpoint" was considered (live ICU discharge). Time to hospital discharge was similar between groups, suggesting that the association with FID is greatest during critical illness and resolves with time. Lack of late differences between groups could also be explained by a type II statistical error. Our study provides no evidence for a relationship between FID as measured by red cell hypochromasia and infection, either as a predisposing or protective factor.
Our findings may be explained by a number of hypotheses. The prevalence of red cell hypochromasia in critical illness and any association with clinical course or outcome has not previously been investigated. Therefore it was not possible to determine the number of patients needed to detect differences between two groups prior to the commencement of the study. As with any study the possibility therefore exists that our findings are due to chance; however, we do not believe this to be the case. Significant differences are seen in the length of stay of the two patient groups. The lack of subsequent differences between the two groups could be due to lack of power of this study.
FID may simply be a marker of nutritional status or general health and not directly responsible for outcome. Nutritional status is an important determinant of immune responses. Protein-energy malnutrition is associated with significant impairment of cell-mediated immunity, phagocyte function, complement activation, secretory immunoglobulin A, antibody concentrations and cytokine production. In addition to iron, the micronutrients zinc, selenium, iron, copper, vitamins A, C, E, and B6 have all been shown to play an important role in the immune system 13 . Research in animals and man has suggested that availability of adequate iron stores is important for many aspects of immune function 14 . FID may predict patients who mount an inadequate or inappropriate immune response. The development of FID may also be an adaptive response to inhibit bacterial multiplication.
Iron is present in all tissues and cells where it is an essential constituent of a number of key enzymes, especially cytochromes, flavoproteins and other mitochondrial iron compounds involved in the oxidative production of cellular energy as adenosine triphosphate. Iron has been shown to play an important role in the proliferation and function of immune cells. Iron deficiency impairs leukocyte function through dysfunction of iron-containing enzyme systems. Impaired humoral function and B cell function have been demonstrated in man and iron-deficient rats 15, 16 . Cell-mediated immunity is impaired with a reduction in production of circulating T cells 17 and differential changes in the lymphocyte subpopulation proliferation 18 . Iron deficiency is associated with a proportional decrease in granulocytes containing myeloperoxidase, an iron-dependent enzyme necessary for phagocytic killing of bacteria 19 . There is reduced capacity for the sudden increase in oxidation involved in phagocytic cells killing ingested organisms 20 . Animal work has also demonstrated impaired Kuppfer cell activity in iron deficiency 21 . Iron excess has been demonstrated to be associated with increased susceptibility to bacterial infection 22 . Low levels of iron have been shown to inhibit the cloning of CD4+ T cells and enhance the function of T suppressor cells 23 . Polymorphonuclear leukocyte phagocytic function has been shown to be impaired with increased iron concentration 24 . An impairment of oxidative metabolism, impaired inactivation of invading micro-organisms and decreased intracellular killing has also been associated with excess free iron 25 . An alternative explanation may be that patients develop red cell hypochromasia (interpreted traditionally as FID) acutely. Red cell hypochromasia as seen in the intensive care population may be an early marker of inflammatory response but not FID. The association between FID and abnormal white cell count, one of the criteria for the diagnosis of SIRS, may support this hypothesis. The increased duration of stay and prolonged duration of SIRS in those patients with FID may underlie an association 
P=0.017, r=0.33
between the nature or extent of the initial inflammatory process not apparent from the observations made. In patients following gastrointestinal surgery, SIRS continuing after postoperative day 3 has been shown to be a predictor of postoperative complications and end-organ dysfunction 11 . Alterations in erythrocyte homeostasis have previously been described during sepsis. An increase in erythrocyte intracellular free cytosolic calcium has been described in septic surgical patients 26 . Rises in erythrocyte calcium are associated with increased cell age and a decrease in membrane deformability 27 . Increased erythrocyte membrane rigidity has been demonstrated to be an early marker of sepsis and infection 28, 29 . The relationship between these changes and red cell hypochromasia has yet to be elucidated.
This study describes the high prevalence of FID as measured by red cell hypochromasia in patients presenting to a teaching hospital intensive care unit and its association with prolonged ICU stay and duration of SIRS. The mechanism is unclear though possibly immunological. There are many interactions between iron and the immune system which may be implicated. We were unable to demonstrate a simple relationship between FID and infection. The possibility also exists that red cell hypochromasia in critical illness does not represent true FID. Further work is required to explore the relationship between FID and immune function in a larger population of critically ill patients.
